|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Kinesiology, School of Public Health, University of Maryland, College Park, Maryland; 2Physical Education and Human Performance, Central Connecticut State University, New Britain, Connecticut; and 3Clinical Research Branch, National Institute on Aging, Harbor Hospital, Baltimore, Maryland
Submitted 3 July 2008 ; accepted in final form 27 August 2008
The R577X polymorphism in the
-actinin-3 encoding gene (ACTN3) has been associated with elite athletic performance, and recently with differences in isometric and dynamic muscle strength and power in the general population. In this study we sought to determine the association of ACTN3 R577X genotype with muscle strength and mass phenotypes in men and women across the adult age span. Eight hundred forty-eight (n = 848) adult volunteers (454 men and 394 women) aged 22–90 yr were genotyped for ACTN3 R577X. Knee extensor (KE) shortening and lengthening peak torque values were determined using isokinetic dynamometry and fat-free mass (FFM) by dual-energy X-ray absorptiometry. Women deficient in
-actinin-3 (X/X; n = 53) displayed lower KE shortening peak torque (30°/s: 89.5 ± 3.5 vs. 99.3 ± 1.4 N·m, P = 0.011; 180°/s: 60.3 ± 2.6 vs. 67.0 ± 1.0 N·m, P = 0.019) and KE lengthening peak torque (30°/s: 122.8 ± 5.7 vs. 137.0 ± 2.2 N·m, P = 0.022; 180°/s: 121.8 ± 5.8 vs. 138.5 ± 2.2 N·m, P = 0.008) compared with R/X + R/R women (n = 341). Women X/X homozygotes also displayed lower levels of both total body FFM (38.9 ± 0.5 vs. 40.1 ± 0.2 kg, P = 0.040) and lower limb FFM (11.9 ± 0.2 vs. 12.5 ± 0.1 kg, P = 0.044) compared with R/X + R/R women. No genotype-related differences were observed in men. In conclusion, our results indicate that the absence of
-actinin-3 protein (i.e., ACTN3 X/X genotype) influences KE peak torque and FFM in women but not men.
genetics; muscle strength; sex differences; skeletal muscle
This article has been cited by other articles:
![]() |
N. Eynon, Y. Meckel, A. J. Alves, C. Yamin, M. Sagiv, E. Goldhammer, and M. Sagiv Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance? Exp Physiol, November 1, 2009; 94(11): 1147 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walsh, B. K. Kelsey, T. J. Angelopoulos, P. M. Clarkson, P. M. Gordon, N. M. Moyna, P. S. Visich, R. F. Zoeller, R. L. Seip, S. Bilbie, et al. CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training J Appl Physiol, October 1, 2009; 107(4): 1235 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Norman, M. Esbjornsson, H. Rundqvist, T. Osterlund, F. von Walden, and P. A. Tesch Strength, power, fiber types, and mRNA expression in trained men and women with different ACTN3 R577X genotypes J Appl Physiol, March 1, 2009; 106(3): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |